Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Heartflow sues AI rival Cleerly | Turning data into actionable insights | FDA clears new algorithms | Key innovations at ACC.26

News You Need to Know Today
Heartflow sues AI rival Cleerly | Turning data into actionable insights | FDA clears new algorithms | Key innovations at ACC.26
Tuesday, April 14, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Artificial intelligence

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products. 

READ MORE >
AI lawsuit court legal
Share on Twitter Share on Facebook Share on Linkedin

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

Share on Twitter Share on Facebook Share on Linkedin
AI lawsuit court legal
According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products. 
READ MORE >

AI turns wearable device data into actionable insights for heart failure patients

Afnan Tariq, MD, discusses early data on a passive, device-agnostic AI platform for heart failure monitoring. “When clinicians are empowered with insights and able to act earlier, you're able to have a durable impact," he said.

READ MORE >
Afnan Tariq, MD, JD, FSCAI, FACC, an interventional cardiologist, assistant clinical professor of medicine at University of California, Irvine, presented first-in-man data on a passive, device-agnostic artificial intelligence (AI) platform for heart failure monitoring using consumer wearables at the recent Technology and Heart Failure Therapeutics (THT) 2026 meeting. The study showed the AI could help lower repeat hospitalizations.
Share on Twitter Share on Facebook Share on Linkedin

AI turns wearable device data into actionable insights for heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
Afnan Tariq, MD, JD, FSCAI, FACC, an interventional cardiologist, assistant clinical professor of medicine at University of California, Irvine, presented first-in-man data on a passive, device-agnostic artificial intelligence (AI) platform for heart failure monitoring using consumer wearables at the recent Technology and Heart Failure Therapeutics (THT) 2026 meeting. The study showed the AI could help lower repeat hospitalizations.
Afnan Tariq, MD, discusses early data on a passive, device-agnostic AI platform for heart failure monitoring. “When clinicians are empowered with insights and able to act earlier, you're able to have a durable impact," he said.
READ MORE >

FDA clears new AI model for detecting signs of cardiac amyloidosis

This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.

READ MORE >
artificial intelligence AI heart cardiology
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI model for detecting signs of cardiac amyloidosis

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI heart cardiology
This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.
READ MORE >

Impactful innovations reshape learning and technology at ACC.26

ACC.26 Chair Kathryn Berlacher, MD, MS, explained some of the big trends at this year's meeting, including AI, CCTA, hands-on training and guideline sessions.

READ MORE >
Kathryn Berlacher, MD, MS, FACC, chair of the 2026 American College of Cardiology (ACC) 2026 Scientific Sessions, and clinical director of cardiology and a women's heart and cardio-obstetrics specialist at the University of Pittsburgh Medical Center, explains the major trend of artificial intelligence (AI) in cardiology, the use of coronary CT angiography (CCTA) for the first time at a medical meeting to scan attendees, and the rise in hands on, guideline, business and advocacy sessions.
Share on Twitter Share on Facebook Share on Linkedin

Impactful innovations reshape learning and technology at ACC.26

Share on Twitter Share on Facebook Share on Linkedin
Kathryn Berlacher, MD, MS, FACC, chair of the 2026 American College of Cardiology (ACC) 2026 Scientific Sessions, and clinical director of cardiology and a women's heart and cardio-obstetrics specialist at the University of Pittsburgh Medical Center, explains the major trend of artificial intelligence (AI) in cardiology, the use of coronary CT angiography (CCTA) for the first time at a medical meeting to scan attendees, and the rise in hands on, guideline, business and advocacy sessions.
ACC.26 Chair Kathryn Berlacher, MD, MS, explained some of the big trends at this year's meeting, including AI, CCTA, hands-on training and guideline sessions.
READ MORE >

FDA clears new AI model for pulmonary hypertension

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

READ MORE >
AI model algorithm tablet digital patient data
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new AI model for pulmonary hypertension

Share on Twitter Share on Facebook Share on Linkedin
AI model algorithm tablet digital patient data
The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.
READ MORE >

Private equity-backed cardiology practice adding new in-house smart lab powered by AI

Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology practice adding new in-house smart lab powered by AI

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.
READ MORE >

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

AI-powered EHR alerts make a world of difference for cardiologists, heart patients

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.
READ MORE >

FDA sees promise in voice-based AI model for heart failure

An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.

READ MORE >
voice audio recording smartphone
Share on Twitter Share on Facebook Share on Linkedin

FDA sees promise in voice-based AI model for heart failure

Share on Twitter Share on Facebook Share on Linkedin
voice audio recording smartphone
An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.
READ MORE >

AI-powered CCTA assessments show ‘close agreement’ with IVUS

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

READ MORE >
Example of an automated artificial intelligence (AI) assessment of soft coronary plaque from a CT scan from the vendor Cleerly. This image shows the AI's reconstruction of a patient's coronary tree and color codes the vessel segments by the amount of overall plaque burden. The AI gives a very detailed report of all the plaque in all the coronary vessels. Some cardiology experts believe this may be the way of the future in screening patients for early coronary disease and monitoring the impact of prevention
Share on Twitter Share on Facebook Share on Linkedin

AI-powered CCTA assessments show ‘close agreement’ with IVUS

Share on Twitter Share on Facebook Share on Linkedin
Example of an automated artificial intelligence (AI) assessment of soft coronary plaque from a CT scan from the vendor Cleerly. This image shows the AI's reconstruction of a patient's coronary tree and color codes the vessel segments by the amount of overall plaque burden. The AI gives a very detailed report of all the plaque in all the coronary vessels. Some cardiology experts believe this may be the way of the future in screening patients for early coronary disease and monitoring the impact of prevention
Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: A historic TAVR approval | Death sentence confirmed for patient-killing nurse | Insulin delivery pods recalled
CMS targets cardiologists | AI turns wearable data into insights | Heart failure after PCI | Prior authorization reducing access
FDA clears next-gen insulin pump | Key issues in EP | New-look valve makes US debut | The benefits of morning exercise
New PE guidelines | FDA clears 'world's smallest camera' | Medtronic's $550M acquisition | J&J launches 3 stroke devices
FDA approves first TAVR system for AR | AKI after TAVR | Injection could heal heart attack damage | Ultra-processed foods
News Alert: FDA approves first TAVR system for aortic regurgitation
AI gets value out of wearable data | Death sentence confirmed for patient-killing nurse | Tributes to a pioneer cardiologist

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …13
    • Page 14
    • Page 15
    • Page 16
    • Current page 17
    • Page 18
    • Page 19
    • Page 20
    • Page 21 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup